Goldman Sachs Group »

Heron Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7M 985k 1.70
2023-09-30 $624k 606k 1.03
2023-06-30 $657k 566k 1.16
2023-03-31 $611k 404k 1.51
2022-12-31 $2.9M 1.2M 2.50
2022-06-30 $3.6M 1.3M 2.79
2022-03-31 $13M 2.3M 5.72
2021-12-31 $18M 1.9M 9.13
2021-09-30 $17M 1.6M 10.69
2021-03-31 $20M 1.2M 16.21
2020-12-31 $24M 1.1M 21.17
2020-09-30 $15M 1.0M 14.82
2020-06-30 $18M 1.2M 14.71
2019-12-31 $36M 1.5M 23.50
2019-09-30 $13M 690k 18.50
2019-06-30 $17M 907k 18.59
2019-03-31 $19M 791k 24.44
2018-12-31 $18M 696k 25.93
2018-09-30 $17M 543k 31.65
2018-06-30 $19M 480k 38.85
2018-03-31 $8.6M 312k 27.60
2017-12-31 $3.4M 186k 18.10
2017-09-30 $5.1M 314k 16.15
2017-06-30 $5.8M 420k 13.85
2017-03-31 $3.4M 228k 15.00
2016-12-31 $370k 28k 13.08
2016-09-30 $749k 43k 17.24
2016-06-30 $317k 18k 18.07
2016-03-31 $5.0M 262k 18.99
2015-12-31 $1.7M 63k 26.71
2015-09-30 $55M 2.2M 24.40
2015-06-30 $476k 15k 31.17
2014-03-31 $234k 17k 13.93